BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26022959)

  • 1. Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis.
    Bandyopadhyay D; Bajaj NS; Zein J; Minai OA; Dweik RA
    Eur Respir J; 2015 Sep; 46(3):750-60. PubMed ID: 26022959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension.
    So PP; Davies RA; Chandy G; Stewart D; Beanlands RS; Haddad H; Pugliese C; Mielniczuk LM
    Am J Cardiol; 2012 May; 109(10):1504-9. PubMed ID: 22385756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: a propensity score analysis.
    Thenappan T; Roy SS; Duval S; Glassner-Kolmin C; Gomberg-Maitland M
    Circ Heart Fail; 2014 Nov; 7(6):903-10. PubMed ID: 25277998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension.
    Provencher S; Herve P; Jais X; Lebrec D; Humbert M; Simonneau G; Sitbon O
    Gastroenterology; 2006 Jan; 130(1):120-6. PubMed ID: 16401475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery.
    Jørgensen ME; Hlatky MA; Køber L; Sanders RD; Torp-Pedersen C; Gislason GH; Jensen PF; Andersson C
    JAMA Intern Med; 2015 Dec; 175(12):1923-31. PubMed ID: 26436291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
    Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
    BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate recovery predicts clinical worsening in patients with pulmonary arterial hypertension.
    Minai OA; Gudavalli R; Mummadi S; Liu X; McCarthy K; Dweik RA
    Am J Respir Crit Care Med; 2012 Feb; 185(4):400-8. PubMed ID: 22108205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
    Farber HW; Miller DP; Meltzer LA; McGoon MD
    J Heart Lung Transplant; 2013 Nov; 32(11):1114-22. PubMed ID: 24035189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups.
    Gall H; Felix JF; Schneck FK; Milger K; Sommer N; Voswinckel R; Franco OH; Hofman A; Schermuly RT; Weissmann N; Grimminger F; Seeger W; Ghofrani HA
    J Heart Lung Transplant; 2017 Sep; 36(9):957-967. PubMed ID: 28302503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era.
    Schaffer JM; Singh SK; Joyce DL; Reitz BA; Robbins RC; Zamanian RT; Mallidi HR
    Circulation; 2013 Jun; 127(25):2503-13. PubMed ID: 23697910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
    Boucly A; Weatherald J; Savale L; Jaïs X; Cottin V; Prevot G; Picard F; de Groote P; Jevnikar M; Bergot E; Chaouat A; Chabanne C; Bourdin A; Parent F; Montani D; Simonneau G; Humbert M; Sitbon O
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit of prostaglandin infusion in severe heart failure: preliminary clinical experience of repetitive administration.
    Serra W; Musiari L; Ardissino D; Gherli T; Montanari A
    Int J Cardiol; 2011 Jan; 146(1):e10-5. PubMed ID: 19176262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis.
    Cam A; Goel SS; Agarwal S; Menon V; Svensson LG; Tuzcu EM; Kapadia SR
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):800-8. PubMed ID: 21320709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocker use is associated with improved outcomes in adult trauma patients.
    Arbabi S; Campion EM; Hemmila MR; Barker M; Dimo M; Ahrns KS; Niederbichler AD; Ipaktchi K; Wahl WL
    J Trauma; 2007 Jan; 62(1):56-61; discussion 61-2. PubMed ID: 17215733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoprolol improves survival in severe traumatic brain injury independent of heart rate control.
    Zangbar B; Khalil M; Rhee P; Joseph B; Kulvatunyou N; Tang A; Friese RS; O'Keeffe T
    J Surg Res; 2016 Feb; 200(2):586-92. PubMed ID: 26365164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.